This review mainly summarises the genetic factors involved in conferring susceptibility to psoriatic arthritis (PsA); nevertheless it is important to underline some aspects concerning genetics of cutaneous psoriasis (Ps) because they often overlap with those of the articular manifestations in patients with PsA. Immunogenetic studies both in Ps and in PsA have investigated the HLA genes, genes within the HLA region and genes outside the HLA region. It is noteworthy that HLA molecules function is to present peptide antigens to T lymphocytes and that this function may explain their association with disease; the differences in their structure are critical in determining the selective capability of presenting specific peptides (arthritogenic?). Nevertheless it is important to consider that the role of HLA alleles may be indirect, and that their association may be simply due to linkage disequilibrium with the gene/s directly involved in the disease susceptibility which are likely to be included in the same extended aplotype. Studies focusing on HLA related genes and genes encoded outside the HLA region have been performed since the specific biologic properties of the molecules encoded by these genes may well explain a possible role in the pathogenesis of chronic inflammatory arthropathy and provide a rationale for the extensive studies on genetic polymorphisms.
In Ps it has been demonstrated a very strong association with the HLA allele Cw6, but only for the type I form (characterised by familial aggregation, moderate/severe skin involvement and clinical onset before the age of 40 years), while no association has been shown for type II (not familial, onset around 55/60 years). Others HLA alleles such as B13, Bw57 and DR7 have been associated with type I Ps but these findings may be due to their linkage disequilibrium with Cw6 (1, 2). Cw*0602 has been shown to be the subtype with the strongest association with early onset, disease severity and higher frequency of guttate form (3, 4) . HLA-Cw6 gene is located on chromosome 6 in a region called PSORS1 which contains some genes possibly implicated in the susceptibility of Ps. Among them the CDSN gene, which encodes corneodesmosin, is one of the major candidate (5-8).
The possible role of HLA-Cw6 in conferring susceptibility to Ps may be explained with its physiological role of presenting peptide antigens to the immune system, while in the case of CDSN a structural alteration of the corneodesmosin protein could be related with a possible role in initiating the pathologic process (8) . Although clear differences have been found among the populations studied, both HLA class I and II alleles have been associated with PsA. Among the first ones, HLA-B13, B17/Cw6, B16 with his splits B38 and B39 (the last one is also associated with disease progression) and B27 are included; among class II alleles, DR7 and DR4 are implicated (9) (10) (11) (12) (13) (14) (15) (16) (17) . The presence of two susceptibility alleles, have been shown to confer an additional risk; this has been demonstrated for Cw1 and B17 when associated with B27 in the spondylitic subset (15) . It has to be point out that the associations of the single HLA alleles are often restricted to specific clinical PsA subsets rather than PsA as a whole. Furthermore some associations, or the statistical significance of them, which have been found in some populations were not confirmed in studies performed on different ethnic groups. On this regard we focus on the association of B13, B17/Cw6 and DR7 with the oligoarticular asymmetric subset (11, (13) (14) (15) , as well as B16 and his splits B38 and B39. Similarly, DR4 has been associated with the peripheral symmetric polyarticular subset (9, 10, 12, 13, 17) while B27 has been classically linked with the axial sacroiliitis involvement (15, 18) , expecially in bilateral sacroiliitis (19) , with the exception of the population in Israel where this association has not been observed (20) . Among the genes encoded within the HLA region the polymorphic gene MICA (MHC class I chain related gene A), located close to B locus and TNF-α and encoding for a stress inducible membrane glycoprotein, has been extensively studied. MICA molecule, found on intestinal epitelial cells and in inflammed synovium, is ligand for NKG2D expressed on NK on CD8+ T lymphocytes and on γδ T cells, with no evidence that it is involved in antigen presentation (21, 22) . Studies performed on caucasian population (23) (24) (25) have demonstrated that MICA-A9 confers susceptibility to PsA independently from Cw*0602 and MICB, TNF-α and DRB1. As demonstrated for other alleles, MICA-A9 preferentially associates with the polyarticular subset. This result has been confirmed by us and others in a multicenter Italian study which has showed also a "gene dosing" effect of MICA-A9 in conferring susceptibility to the polyarticular subset in overlap with axial involvement (Mameli et al. submitted). Among other genes, TNF-α polymorphisms appear to be some of the most interesting because of their functional and pathogenetic role. In Ps, a positive association has been described for Ps vulgaris, but not pustolosis palmoplantaris, with -238 and -308 promoter polymorphysms (26) . Considering PsA, the data so far available are conflicting (27) (28) (29) (30) (31) . A recent study on three microsatellite and two TNF-α promoter polymorphisms showed a significant increase of TNFa6c1d3 aplotype in PsA patients compared with Ps alone, and a decrease in -308 compared to normal controls. It is noteworthy that TNFa6 microsatellite is associated with a decreased TNF-α production (27) . Other studies did not report significant associations between TNF-α polymorphisms and PsA, while more recently, in a Canadian study, it has been described a significant association of -238A TNF-α polymorphism and PsA (31). In conclusion, this short review focus on the complexity of the genetic susceptibility to Ps and PsA; the variety of the clinical features makes the understanding of the pathogenetic mechanisms even more difficult to achieve. On the other hand, the different susceptibility factors related with the different clinical subsets may, in turn, become the key to the understanding of the genetic mechanisms of disease susceptibility and of the role of the environmental factors involved.
